Macular Degeneration Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been taking hydroxychloroquine (a medication commonly used for conditions like lupus or rheumatoid arthritis) for more than 10 years.
Who may not be able to join:
- People who have existing eye conditions that could look similar to, or interfere with the detection of, eye damage caused by hydroxychloroquine.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rita Anjos, MD, ULS São José
Phone: +351 914535963
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To develop an automated screening method in hydroxychloroquine (HCQ) screening based on OCT features
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.